冠心病合理用药指南(第2版)

2018-03-01 国家卫生计生委合理用药专家委员会《中国医学前沿杂志(电子版)》

2018年3月1日，由国家卫生计生委合理用药专家委员会和中国药师协会组成指南修订联合委员会，经 3 次联合会议讨论后最终确定了指南修订的总体原则及新指南拟回答的核心问题。

中文标题：

冠心病合理用药指南(第2版)

发布机构：

国家卫生计生委合理用药专家委员会

发布日期：

2018-03-01

简要介绍：

2018年3月1日，由国家卫生计生委合理用药专家委员会和中国药师协会组成指南修订联合委员会，经 3 次联合会议讨论后最终确定了指南修订的总体原则及新指南拟回答的核心问题。指南工作组针对这些核心问题制定了具体的文献检索和评价策略，综合评价、筛选出相关文献。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=9d70f1c00216e3cd, title=冠心病合理用药指南(第2版), enTitle=, guiderFrom=《中国医学前沿杂志(电子版)》, authorId=0, author=, summary=2018年3月1日，由国家卫生计生委合理用药专家委员会和中国药师协会组成指南修订联合委员会，经 3 次联合会议讨论后最终确定了指南修订的总体原则及新指南拟回答的核心问题。, cover=https://img.medsci.cn/2021829/1630250153722_5579292.png, journalId=0, articlesId=null, associationId=1325, associationName=国家卫生计生委合理用药专家委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Mar 01 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>2018年3月1日，由国家卫生计生委合理用药专家委员会和中国药师协会组成指南修订联合委员会，经 3 次联合会议讨论后最终确定了指南修订的总体原则及新指南拟回答的核心问题。指南工作组针对这些核心问题制定了具体的文献检索和评价策略，综合评价、筛选出相关文献。</p> </div> </div> </div>, tagList=[TagDto(tagId=703, tagName=冠心病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=703, guiderKeyword=冠心病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4618, appHits=937, showAppHits=0, pcHits=744, showPcHits=3670, likes=6, shares=118, comments=29, approvalStatus=1, publishedTime=Mon Aug 30 09:48:22 CST 2021, publishedTimeString=2018-03-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Aug 29 23:16:01 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 11:25:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_冠心病合理用药指南(第2版).pdf)])

_冠心病合理用药指南(第2版).pdf

下载请点击：

评论区 (23)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2094796, encodeId=fdd62094e9611, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Wed Oct 19 19:50:32 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226948, encodeId=091e12269485a, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 17 01:58:43 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199635, encodeId=10e4119963541, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dff1956483, createdName=1e1275afm36(暂无匿称), createdTime=Sat Mar 05 13:06:38 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195774, encodeId=79a41195e74c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18034000901, createdName=139fe8b3m05暂无昵称, createdTime=Mon Feb 21 17:32:04 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187290, encodeId=5a23118e29023, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 21:33:56 CST 2022, time=2022-01-22, status=1, ipAttribution=)]
2022-10-19 ms3000000190198551

学习学习

84 0
[GetPortalCommentsPageByObjectIdResponse(id=2094796, encodeId=fdd62094e9611, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Wed Oct 19 19:50:32 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226948, encodeId=091e12269485a, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 17 01:58:43 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199635, encodeId=10e4119963541, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dff1956483, createdName=1e1275afm36(暂无匿称), createdTime=Sat Mar 05 13:06:38 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195774, encodeId=79a41195e74c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18034000901, createdName=139fe8b3m05暂无昵称, createdTime=Mon Feb 21 17:32:04 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187290, encodeId=5a23118e29023, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 21:33:56 CST 2022, time=2022-01-22, status=1, ipAttribution=)]
2022-06-17 ms6000000225486324

学习了，很好

90 0
[GetPortalCommentsPageByObjectIdResponse(id=2094796, encodeId=fdd62094e9611, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Wed Oct 19 19:50:32 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226948, encodeId=091e12269485a, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 17 01:58:43 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199635, encodeId=10e4119963541, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dff1956483, createdName=1e1275afm36(暂无匿称), createdTime=Sat Mar 05 13:06:38 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195774, encodeId=79a41195e74c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18034000901, createdName=139fe8b3m05暂无昵称, createdTime=Mon Feb 21 17:32:04 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187290, encodeId=5a23118e29023, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 21:33:56 CST 2022, time=2022-01-22, status=1, ipAttribution=)]
2022-03-05 1e1275afm36(暂无匿称)

学习了

86 0
[GetPortalCommentsPageByObjectIdResponse(id=2094796, encodeId=fdd62094e9611, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Wed Oct 19 19:50:32 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226948, encodeId=091e12269485a, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 17 01:58:43 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199635, encodeId=10e4119963541, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dff1956483, createdName=1e1275afm36(暂无匿称), createdTime=Sat Mar 05 13:06:38 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195774, encodeId=79a41195e74c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18034000901, createdName=139fe8b3m05暂无昵称, createdTime=Mon Feb 21 17:32:04 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187290, encodeId=5a23118e29023, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 21:33:56 CST 2022, time=2022-01-22, status=1, ipAttribution=)]
2022-02-21 139fe8b3m05暂无昵称

好

81 0
[GetPortalCommentsPageByObjectIdResponse(id=2094796, encodeId=fdd62094e9611, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Wed Oct 19 19:50:32 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226948, encodeId=091e12269485a, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Fri Jun 17 01:58:43 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199635, encodeId=10e4119963541, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dff1956483, createdName=1e1275afm36(暂无匿称), createdTime=Sat Mar 05 13:06:38 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195774, encodeId=79a41195e74c0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18034000901, createdName=139fe8b3m05暂无昵称, createdTime=Mon Feb 21 17:32:04 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187290, encodeId=5a23118e29023, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9dc96478592, createdName=ms2000001716855301, createdTime=Sat Jan 22 21:33:56 CST 2022, time=2022-01-22, status=1, ipAttribution=)]
2022-01-22 ms2000001716855301

好的

76 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

冠心病合理用药指南(第2版)

相关指南

拓展阅读

科室

工具

服务